CYP2E1 and metabolic dysfunction-associated steatotic liver disease: It is hypothesized that in the case of fat mobilisation as in diabetes mellitus, the hyperketonemia and other small organic molecules are both substrates and inducers of CYP2E1 that will lead to non-alcoholic fatty liver disease.